Recent developments and strategies in pediatric pharmacology research in the USA
2008

Recent Developments in Pediatric Pharmacology Research

publication Evidence: moderate

Author Information

Author(s): Benedetto Vitiello

Primary Institution: National Institute of Mental Health

Hypothesis

What are the recent developments and strategies in pediatric pharmacology research in the USA?

Conclusion

Research in pediatric pharmacology has significantly expanded due to increased public funding and industry incentives.

Supporting Evidence

  • Pediatric pharmacology research has expanded significantly in the last decade.
  • Legislation has provided financial incentives for industry to conduct pediatric studies.
  • Public funding has supported research on off-patent medications and treatment comparisons.

Takeaway

Researchers are learning more about how medications affect children, thanks to more studies being done and new laws encouraging this research.

Methodology

The review discusses recent developments in pediatric pharmacology, focusing on psychiatric medications and the roles of public and private funding.

Potential Biases

Industry-sponsored research may lead to biased results due to control over data publication.

Limitations

The studies conducted may not always address actual pediatric needs and can be influenced by the sponsors.

Digital Object Identifier (DOI)

10.1186/1753-2000-2-36

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication